A Phase II Clinical Trial of Anti-PD-1 Antibody SHR-1210 Versus Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
Latest Information Update: 08 Oct 2021
At a glance
- Drugs Camrelizumab (Primary) ; Capecitabine; Cisplatin
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
Most Recent Events
- 31 Jan 2019 New trial record